Press release
The biopharmaceutical contract manufacturing market is estimated to be worth USD 13.9 billion in 2030, predicts Roots Analysis
Roots Analysis is pleased to announce the publication of its recent study, titled, “Biopharma Contract Manufacturing Market (3rd Edition), 2019-2030.”
For more information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/biopharma-contract-manufacturing-market-3rd-edition-2019-2030/250.html
The report features an extensive study on the contract service providers within the biopharmaceutical industry. The study features in-depth analysis, highlighting the capabilities of a diverse set of biopharmaceutical CMOs and CDMOs. Amongst other elements, the report includes:
A detailed review of the overall landscape of the biopharmaceutical contract manufacturing market, featuring a comprehensive list of active CMOs and detailed analysis of the manufacturing service providers based on a number of parameters.
Elaborate profiles of key players that have a diverse range of capabilities for the development, manufacturing, and packaging of biologics.
A detailed discussion on the key enablers in this domain, including certain niche product classes, which are likely to have a significant impact on the growth of the contract services market.
A case study on the growing global biosimilars market, highlighting the opportunities for biopharmaceutical CMOs and CDMOs.
A case study comparing the key characteristics of large molecule and small molecule drugs, along with details on the various steps involved in their respective manufacturing processes.
A discussion on challenges related to in-house manufacturing, featuring a brief overview of the various parameters that a drug / therapy developer may need to take into consideration while deciding whether to manufacture its products in-house or outsource.
An analysis of the recent collaborations (signed since 2013) focused on the contract manufacturing of biologics.
A detailed analysis of the various mergers and acquisitions that have taken place in this domain, highlighting the trend in the number of companies acquired between 2013-2018, along with the geographical distribution of this activity.
An in-depth analysis of more than 490 grants that have been awarded to research institutes engaged in next generation immune checkpoint therapy-related projects.
An analysis on the recent trends within biopharmaceutical contract manufacturing industry, highlighting various facility and capability expansions.
A detailed capacity analysis, taking into consideration the individual development and manufacturing capacities of various stakeholders.
A detailed capacity analysis, taking into consideration the individual development and manufacturing capacities of various stakeholders.
A discussion on affiliated trends, key drivers, and challenges, under a comprehensive SWOT framework.
A survey analysis featuring inputs solicited from various experts who are directly / indirectly involved in providing CMO services to medical device developers.
A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
Commonly Outsourced Business Operations
Active Pharmaceutical Ingredients (API)
Finished Dosage Formulations (FDF)
Types of Expression System
Mammalian
Microbial
Others
Company Size
Small
Mid-Sized
Large and Very Large
Scale of Operation
Preclinical
Clinical
Commercial
Key Geographical Region
North America
Europe
Asia-Pacific
Rest of the World
The report also features detailed transcripts of discussions held with the following experts:
Astrid Brammer, Senior Manager Business Development, Richter-Helm Mathias Schmidt (Chief Executive Officer, ArmaGen)
Birgit Schwab, Senior Manager Strategic Marketing, Rentschler Biotechnologie
Christian Bailly, Director of CDMO, Pierre Fabre
Claire Otjes, Assistant Marketing Manager, Batavia Biosciences
David C Cunningham, Director Corporate Development, Goodwin Biotechnology
Dietmar Katinger, Chief Executive Officer, Polymun Scientific
Denis Angioletti, Chief Commercial Officer, Cerbios-Pharma
Jeffrey Hung, Chief Commercial Officer, Vigene Biosciences
Kevin Daley, Director Pharmaceuticals, Novasep
Mark Wright, Site Head, Grangemouth, Piramal Healthcare
Nicolas Grandchamp, R&D Leader, GEG Tech
Raquel Fortunato, Chief Executive Officer, GenIbet Biopharmaceuticals
Sebastian Schuck, Head of Business Development, Wacker Biotech
Stephen Taylor, Senior Vice President Commercial, FUJIFILM Diosynth Biotechnologies
Tatjana Buchholz, Marketing Manager, PlasmidFactory and Marco Schmeer, Project Manager, PlasmidFactory
Tim Oldham, Chief Executive Officer, Cell Therapies
Key companies covered in the report
3P Biopharmaceuticals
Abzena
Albany Molecular Research
BioVectra
BioXcellence (Boehringer Ingelheim)
Celonic
Charles River Laboratories
ChemPartner
Cobra Biologics
CordenPharma
Cytovance Biologics
GE Healthcare
Goodwin Biotechnology
Grand River Aseptic Manufacturing
IDT Biologika
KBI BioPharma
Kemwell Biopharma
LFB Biomanufacturing
Meridian Life Science
Patheon
Pfizer CentreOne
PX'Therapeutics
Samsung BioLogics
Sanofi, CEPiA
Thermo Fisher Scientific
Vetter Pharma International
For more information please click on the following link:
Biopharma Contract Manufacturing Market (3rd Edition), 2019-2030 (https://www.rootsanalysis.com/reports/view_document/biopharma-contract-manufacturing-market-3rd-edition-2019-2030/250.html)
Other Recent Offerings
1. Cell Therapy Manufacturing Market (3rd Edition), 2019-2030
2. Antibody Contract Manufacturing Market, 2020-2030
3. China Biopharmaceutical Contract Manufacturing Market, 2020-2030
4. Peptide Therapeutics: Contract API Manufacturing Market, 2020-2030
Contact:
Gaurav Chaudhary
gaurav.chaudhary@rootsanalysis.com
Roots Analysis
A430, 4th Floor,
Bestech Business Towers, Sector 66, Mohali, India
sales@rootsanalysis.com
+1 (415) 800 3415
+44 (122) 391 1091
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The biopharmaceutical contract manufacturing market is estimated to be worth USD 13.9 billion in 2030, predicts Roots Analysis here
News-ID: 2208627 • Views: …
More Releases from Roots Analysis
Autoinjectors Market CAGR to Exceed 6.2% by 2035, Due To The Growing Demand For …
According to our latest market report "Global Autoinjectors Market" by Usability, Route of Administration, Type of Molecule Delivered, Type of Actuation Mechanism, Volume of Container, End User, Target Indication and Key Geographical Regions: Industry Trends and Global Forecasts, till 2035", the global autoinjectors market size is projected to reach around USD 176 billion by 2035 from USD 96.2 billion, growing at a CAGR of 6.2% in the forecast period 2024-2035.…
Medical Aesthetics Market CAGR To Be Around 9.4% by 2035, Due To The Growing Dem …
According to our latest market report "Medical Aesthetics Market, Till 2035 by Type of Products and / or Devices Offered, Type of Procedure, End-user, Gender, Distribution Channel and Key Geographical Regions: Industry Trends and Global Forecasts", the global medical aesthetics market size is projected to reach USD 102 billion by 2035 from USD 35 billion in 2023, growing at a CAGR of 9.4% in the forecast period 2023-2035.
The increasing…
In Vitro Diagnostics Market Size to Hit USD 190 billion by 2035 | Exclusive Repo …
The In Vitro Diagnostics Market size was valued at USD 108 billion in 2024 and likely to hit over USD 190 billion by 2035, growing at a CAGR of 5.2% during the forecast period 2024 to 2035
In vitro diagnostics (IVD) are the tests conducted on samples retrieved from human body, such as blood, saliva or tissue in order to detect diseases or conditions. Such tests help diagnose, monitor, and manage…
Skincare Market Revenue to Cross USD 405 billion by 2035 | Roots Analysis
According to our latest market report "Skincare Market by Type of Product by Application, Type of Product by Body Part, Distribution Channel, Type of Offline Distribution Channel, Type of Packaging, Product Category, Gender, Type of Ingredient, and Geography: Industry Trends and Global Forecasts, till 2035", the global skincare market size is projected to reach USD 407 billion by 2035 from USD 185 billion in 2024, growing at a CAGR of…
More Releases for Mark
Impressionist landscape artist - Mark Briscoe
I am Mark Briscoe, Bristish artist well established in the field of Chinoiserie furniture decoration and restoration of antique lacquer. But the techniques for fine art easel painting in the wonderful manner of the old masters is something which I have been exploring in great earnest over the last two years as a long cherished desire. And while I cannot claim to have come anywhere near their heights, I have…
Intellias Reaches 1000-Employee Mark
On June 4, 2018, Intellias welcomed its 1000th employee. The company is proud to reach such a high bar and sees this number as a new starting point to reaching 2000 people onboard and landing in the top 10 Ukrainian IT companies by headcount. As of today, Intellias has three development centers in Lviv, Kyiv, and Odessa as well as a representative office in Berlin. The 1000th employee will join…
Global Data Destruction Software Market 2017 : Darik Horn, Apple, UCSD, Mark Lor …
Data Destruction Software Market 2017
A market study based on the " Data Destruction Software Market " across the globe, recently added to the repository of Market Research, is titled ‘Global Data Destruction Software Market 2017’. The research report analyses the historical as well as present performance of the worldwide Data Destruction Software industry, and makes predictions on the future status of Data Destruction Software market on the basis of this…
Mark de Clive-Lowe
On Thursday, May 3rd, 2012 internationally known musician Mark de Clive-Lowe (MdCL), will take the stage at The Beehive, located in Boston, MA, for a special performance of his revolutionary sound. Be there from 9:30PM to 1:00AM as MdCL plays impromptu remixes created from scratch, on the spot using drum machines, keyboards and special effects. He will start with a jazz-oriented set and crank up the intensity with his signature…
Trade Mark Act
Neoinfo Solutions Pvt. LTD is an IT based company with its main office located in Jaipur(rajasthan). Our expertise lies in the domain of Website Designing development portal development,maintenance software consulting, designing development , implimentation, training and maitenance.In the journey of achieving our combined business and social goals we have kept in mind and have always strictly followed all our data security policies to ensure that all informations of our clients…
Trade mark Act
Neoinfo Solutions Pvt. LTD is an IT based company with its main office located in Jaipur(rajasthan). Our expertise lies in the domain of Website Designing development portal development,maintenance software consulting, designing development , implimentation, training and maitenance.In the journey of achieving our combined business and social goals we have kept in mind and have always strictly followed all our data security policies to ensure that all informations of our clients…
